Skip to main content
Clinical Trials/NCT02938052
NCT02938052
Completed
N/A

Developing a Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: proof-of Concept Trial

Massachusetts General Hospital1 site in 1 country10 target enrollmentDecember 6, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congestive Heart Failure
Sponsor
Massachusetts General Hospital
Enrollment
10
Locations
1
Primary Endpoint
Feasibility of the PP-based Health Behavior Intervention
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The focus of this study is to examine the feasibility, acceptability, and preliminary impact of our customized positive psychology (PP)-based health behavior intervention in a group of patients with mild to moderate heart failure (HF).

Detailed Description

The investigators are proposing a study that will specifically and innovatively focus on the development of a novel positive psychology intervention that is adapted for patients with HF. The MGH inpatient units and MGH Heart Center outpatients will serve as the source of subjects for the study, with patients who have a diagnosis of HF serving as potential subjects. The investigators will enroll 10 HF patients, who will take part in an 10-week PP-based health behavior intervention. In this project, the investigators hope to do the following: 1. Test an 10-week, telephone-delivered health behavior intervention utilizing PP exercises and systematic goal-setting in a brief, non-randomized, proof-of-concept trial (N=10). 2. Determine whether this initial intervention is feasible in a small cohort of HF patients. 3. Explore potential benefits of the intervention on outcomes of interest (e.g., optimism, positive affect). Baseline information about enrolled participants will be obtained from the patients, care providers, and the electronic medical record as required for characterization of our population. This information will include data regarding medical history (history of prior acute coronary syndrome, coronary artery bypass graft, congestive HF, hypertension, diabetes mellitus, hyperlipidemia, and current smoking), current medical variables (renal function, left ventricular ejection fraction, NYHA class), medications, and sociodemographic data (age, gender, race/ethnicity, living alone). Participants will under go an initial visit during which they will meet with study staff in person (or if preferred over the phone). • They will fill out baseline questionnaires, and be provided a treatment manual with weekly exercises, along with a copy of Learning to Live with Heart Failure. The PP and goal-setting portions of the intervention will be introduced, and the first exercise will be assigned. Finally, participants will be provided an ActiGraph accelerometer to wear for 7 days, as well as a personal step counter to keep. Participants will undergo weekly phone sessions for 10 weeks. * For the positive psychology segment the participant will review the previous week's exercise, discuss of the rationale of the next week's exercise, and be assigned the next week's exercise. * For the goal-setting segment the participant will review the health goal from the prior week, receive education about a health behavior, discuss ways to improve health behaviors, and set a goal for the next week. Participants will undergo a follow-up phone call at 10 weeks that asks the same questions that were answered during the initial visit, as well as questions about their experience using the ActiGraph. • At Week 10, participants will wear another ActiGraph for 7 days.

Registry
clinicaltrials.gov
Start Date
December 6, 2016
End Date
August 10, 2017
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christopher Celano

Assistant in Psychiatry

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients with NYHA class I, II, or III HF admitted to an MGH inpatient unit or outpatients at the MGH Heart Center. Patients with NYHA class IV HF have ongoing HF symptoms at rest, making it difficult for them to increase physical activity and other health behaviors; therefore, they will not be included. HF diagnosis will be confirmed via chart review and with the patient's treatment team as needed.
  • Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS SAS) items regarding diet/exercise/medications. The MOS SAS has been used in multiple prior studies assessing adherence in cardiac patients, including our own studies in this population. This threshold score on the MOS SAS will ensure that all participants will have the potential to improve their health behaviors.

Exclusion Criteria

  • Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test that is sensitive and specific for screening for cognitive impairment in research participants.
  • Medical conditions precluding interviews or likely to lead to death within 6 months.
  • Inability to speak English, inability to read or write, inability to walk, or lack of a telephone.

Outcomes

Primary Outcomes

Feasibility of the PP-based Health Behavior Intervention

Time Frame: 10 weeks

Feasibility will be measured by examining the number of completed exercises.

Secondary Outcomes

  • Changes in HADS-Anxiety Subscale Scores(Change in score from Baseline to 10 weeks)
  • Change in HADS-Depression Subscale Scores(Change in score from Baseline to 10 weeks)
  • Changes in Daily Sodium Intake (as Measured With the SSQ)(Change in score from Baseline to 10 weeks)
  • Change in Physical Activity(Baseline and 10 weeks)
  • Changes in PANAS Scores(Change in score from Baseline to 10 weeks)
  • Changes in LOT-R Scores(Change of score from Baseline to 10 weeks)
  • Changes in KCCQ Scores(Change in score from Baseline to 10 weeks)
  • Changes in SF-12 Scores(Change in score from Baseline to 10 weeks)
  • Acceptability of the Exercises: Utility Score(Weeks 1-10)
  • Changes in MOS SAS Scores(Change in score from Baseline to 10 weeks)
  • Acceptability of the Exercises: Ease Score(Weeks 1-10)
  • Immediate Impact of the Exercises: Optimism Rating(Weeks 1-10)
  • Self-Reported Medication Adherence (SRMA)(Change in score from Baseline to 10 weeks)
  • Change in Moderate to Vigorous Physical Activity (Actigraph)(Change in MVPA from Baseline to 10 weeks)
  • Feasibility of Actigraph(Baseline and 10 weeks)
  • Immediate Impact of the Exercises: Positive Affect Rating(Weeks 1-10)

Study Sites (1)

Loading locations...

Similar Trials